WO1997015555A3 - Imidazolderivate und deren verwendung als stickstoffmonoxid-synthase-inhibitoren - Google Patents
Imidazolderivate und deren verwendung als stickstoffmonoxid-synthase-inhibitoren Download PDFInfo
- Publication number
- WO1997015555A3 WO1997015555A3 PCT/DE1996/002079 DE9602079W WO9715555A3 WO 1997015555 A3 WO1997015555 A3 WO 1997015555A3 DE 9602079 W DE9602079 W DE 9602079W WO 9715555 A3 WO9715555 A3 WO 9715555A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nitrogen monoxide
- imidazole derivatives
- synthase inhibitors
- monoxide synthase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96944573A EP0857171A2 (de) | 1995-10-25 | 1996-10-24 | Imidazolderivate und deren verwendung als stickstoffmonoxid-synthase-inhibitoren |
AU13009/97A AU1300997A (en) | 1995-10-25 | 1996-10-24 | Imidazole derivatives and the use thereof as nitrogen monoxide synthase inhibitors |
JP9516208A JPH11515008A (ja) | 1995-10-25 | 1996-10-24 | イミダゾール誘導体及びその一酸化窒素合成酵素阻害剤としての使用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19541146.3 | 1995-10-25 | ||
DE19541146A DE19541146A1 (de) | 1995-10-25 | 1995-10-25 | Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997015555A2 WO1997015555A2 (de) | 1997-05-01 |
WO1997015555A3 true WO1997015555A3 (de) | 1997-07-10 |
Family
ID=7776625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1996/002079 WO1997015555A2 (de) | 1995-10-25 | 1996-10-24 | Imidazolderivate und deren verwendung als stickstoffmonoxid-synthase-inhibitoren |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0857171A2 (de) |
JP (1) | JPH11515008A (de) |
AU (1) | AU1300997A (de) |
CA (1) | CA2235621A1 (de) |
DE (1) | DE19541146A1 (de) |
WO (1) | WO1997015555A2 (de) |
ZA (1) | ZA969019B (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19627310A1 (de) * | 1996-06-27 | 1998-01-02 | Schering Ag | Imidazolderivate als Stickstoffmonoxid-Synthase-Inhibitoren |
DE69715769T2 (de) * | 1996-11-04 | 2003-05-28 | Bayer Cropscience S.A., Lyon | 1-Polyarylpyrazole als Pestizide |
EP1186296B1 (de) * | 1999-05-25 | 2007-04-18 | Mitsubishi Pharma Corporation | PROMOTOREN FüR DIE EXPRESSION DES MYELIN ASSOZIIERTEN GLYCOPROTEINS (MAG) |
AUPQ142599A0 (en) * | 1999-07-05 | 1999-07-29 | Fujisawa Pharmaceutical Co., Ltd. | New amide compounds |
US6525051B2 (en) * | 2000-03-27 | 2003-02-25 | Schering Aktiengesellschaft | N-heterocyclic derivatives as NOS inhibitors |
AU2001264223A1 (en) * | 2000-06-28 | 2002-01-08 | Ssp Co., Ltd. | Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts |
EP1178038A1 (de) * | 2000-08-04 | 2002-02-06 | Aventis Cropscience S.A. | Fungizide Phenylamidin Derivative |
NZ528450A (en) | 2001-05-11 | 2006-02-24 | Biovitrum Ab | Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders |
US7718650B2 (en) | 2001-05-11 | 2010-05-18 | Biovitrum Ab | Aryl sulfonamide compounds for treating obesity |
PL375375A1 (en) * | 2002-08-02 | 2005-11-28 | Pharmacia Corporation | Methods for treatment and prevention of gastrointestinal conditions |
US7449481B2 (en) * | 2004-04-13 | 2008-11-11 | Cephalon, Inc. | Thio-substituted biaryl-methanesulfinyl derivatives |
US20070123572A1 (en) * | 2005-11-28 | 2007-05-31 | Kalypsys, Inc. | Novel method of preparation of 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole and (3-imidazol-1-yl-[1,2,4]thiadiazol-5yl)-dialkyl-amines |
JP2008521908A (ja) * | 2004-12-01 | 2008-06-26 | カリプシス・インコーポレーテッド | 誘導型一酸化窒素シンターゼ阻害剤 |
EP1741708A1 (de) * | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl substituierte Amide mit ungesättigtem oder zyklischem Linker, und deren Verwendung als Pharmaka |
WO2007039580A1 (en) * | 2005-10-05 | 2007-04-12 | Nycomed Gmbh | Imidazolyl-substituted benzophenone compounds |
WO2007039578A1 (en) * | 2005-10-05 | 2007-04-12 | Nycomed Gmbh | Imidazolyl-substituted azabenzophenone compounds |
EP2674417A3 (de) * | 2007-11-21 | 2014-04-09 | Decode Genetics EHF | Biaryl-PDE4-Inhibitoren zur Behandlung von Entzündungen |
AU2010234526B2 (en) | 2009-04-06 | 2016-07-21 | Agios Pharmaceuticals, Inc. | Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use |
NZ597379A (en) | 2009-06-29 | 2014-04-30 | Agios Pharmaceuticals Inc | Therapeutic compounds and compositions |
DK2448581T3 (en) | 2009-06-29 | 2017-03-13 | Agios Pharmaceuticals Inc | Therapeutic compositions and methods for their applications |
WO2012083246A1 (en) | 2010-12-17 | 2012-06-21 | Agios Pharmaceuticals, Inc. | Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators |
CA2822432C (en) | 2010-12-21 | 2019-09-24 | Agios Pharmaceuticals, Inc. | Bicyclic pkm2 activators |
TWI549947B (zh) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
US9181231B2 (en) | 2011-05-03 | 2015-11-10 | Agios Pharmaceuticals, Inc | Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia |
CN108451955B (zh) | 2011-05-03 | 2022-02-01 | 安吉奥斯医药品有限公司 | 用于治疗的丙酮酸激酶活化剂 |
WO2014139144A1 (en) | 2013-03-15 | 2014-09-18 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US9206211B2 (en) | 2013-04-17 | 2015-12-08 | Massachusetts Institute Of Technology | Metathesis catalysts and methods thereof |
CN105439946B (zh) * | 2014-08-13 | 2018-02-02 | 益方生物科技(上海)有限公司 | 羧酸化合物及其制备方法和用途 |
PL3307271T3 (pl) | 2015-06-11 | 2024-02-05 | Agios Pharmaceuticals, Inc. | Sposoby stosowania aktywatorów kinazy pirogronianowej |
TWI780281B (zh) * | 2017-12-14 | 2022-10-11 | 丹麥商Nmd藥品公司 | 用於治療神經肌肉病症的化合物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3541109A (en) * | 1968-06-25 | 1970-11-17 | Du Pont | 1-substituted imidazoles useful in acth reserve assay |
FR2267101A1 (de) * | 1974-04-11 | 1975-11-07 | Schering Ag | |
EP0270091A1 (de) * | 1986-12-02 | 1988-06-08 | Tanabe Seiyaku Co., Ltd. | Imidazol-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zubereitungen, welche diese enthalten, Verwendung dieser zur Herstellung therapeutisch wirksamer Arzneimittel und Zwischenprodukte, welche beim Herstellungsverfahren entstehen |
EP0385850A2 (de) * | 1989-03-03 | 1990-09-05 | Laboratoires Upsa | Benzimidazol- und Azabenzimidazol-Derivate, Verfahren zu deren Herstellung, Synthese-Zwischenprodukte, diese enthaltende pharmazeutische Zusammensetzungen, verwendbar bei der Behandlung von Herzgefässerkrankungen und duodenalem Ulcus |
DE3942475A1 (de) * | 1989-12-22 | 1991-06-27 | Basf Ag | Substituierte salicylsaeurealkylester und verfahren zu ihrer herstellung |
-
1995
- 1995-10-25 DE DE19541146A patent/DE19541146A1/de not_active Withdrawn
-
1996
- 1996-10-24 JP JP9516208A patent/JPH11515008A/ja active Pending
- 1996-10-24 WO PCT/DE1996/002079 patent/WO1997015555A2/de not_active Application Discontinuation
- 1996-10-24 AU AU13009/97A patent/AU1300997A/en not_active Abandoned
- 1996-10-24 EP EP96944573A patent/EP0857171A2/de not_active Withdrawn
- 1996-10-24 CA CA002235621A patent/CA2235621A1/en not_active Abandoned
- 1996-10-25 ZA ZA969019A patent/ZA969019B/xx unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3541109A (en) * | 1968-06-25 | 1970-11-17 | Du Pont | 1-substituted imidazoles useful in acth reserve assay |
FR2267101A1 (de) * | 1974-04-11 | 1975-11-07 | Schering Ag | |
EP0270091A1 (de) * | 1986-12-02 | 1988-06-08 | Tanabe Seiyaku Co., Ltd. | Imidazol-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zubereitungen, welche diese enthalten, Verwendung dieser zur Herstellung therapeutisch wirksamer Arzneimittel und Zwischenprodukte, welche beim Herstellungsverfahren entstehen |
EP0385850A2 (de) * | 1989-03-03 | 1990-09-05 | Laboratoires Upsa | Benzimidazol- und Azabenzimidazol-Derivate, Verfahren zu deren Herstellung, Synthese-Zwischenprodukte, diese enthaltende pharmazeutische Zusammensetzungen, verwendbar bei der Behandlung von Herzgefässerkrankungen und duodenalem Ulcus |
DE3942475A1 (de) * | 1989-12-22 | 1991-06-27 | Basf Ag | Substituierte salicylsaeurealkylester und verfahren zu ihrer herstellung |
Non-Patent Citations (15)
Title |
---|
A. L. JOHNSON ET. AL.: "The Synthesis of 1-Arylimidazoles, a New Class of Steroid Hydroxylation Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, vol. 12, no. 6, November 1969 (1969-11-01), WASHINGTON DC, US, pages 1024 - 8, XP000653294 * |
BRITISH JOURNAL OF PHARMACOLOGY, vol. 119, no. 2, 1996, pages 423 - 31 * |
C. ESCOLASTICO ET. AL.: "Imidazole and Benzimidazole Addition to Quinones. Formation of meso and d,l Isomers and Crystal Structure of the d,l Isomer of 2,3-Bis(benzimidazol-1'-yl)- 1,4-Dihydroxybenzene.", TETRAHEDRON, vol. 50, no. 43, 1994, OXFORD, GB, pages 12489 - 12510, XP000652111 * |
CHEMICAL ABSTRACTS, vol. 125, no. 21, 18 November 1996, Columbus, Ohio, US; abstract no. 265016r, R. L. HANDY ET. AL.: "Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole." page 38; column 1; XP002029806 * |
D. J. WOLFFE ET. AL.: "Calmodulin-dependent Nitric-oxide Synthase", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 13, 5 May 1993 (1993-05-05), ROCKVILLE PIKE, US, pages 9425 - 9, XP000652112 * |
D. M. ZIMMERMANN ET. AL.: "Structure-activity Relationships of trans-3,4-Dimethyl-4-(3-hydroxyphenyl)-piperidine Antagonists for mu and kappa-Opioid Receptors.", JOURNAL OF MEDICINAL CHEMISTRY, vol. 36, no. 20, 1 October 1993 (1993-10-01), WASHINGTON DC, US, pages 2964 - 72, XP002029805 * |
D. POORANCHAND ET. AL.: "Reaction of Dimethyl N-aryl and N-alkylcarbonimidodithioates with Aminoacetaldehyde Diethyl Acetal. A Direct Synthesis of 1-Aryl and 1-Alkyl-2-methylthioimidazoles.", SYNTHESIS, no. 12, December 1987 (1987-12-01), STUTTGART, DE, pages 1136 - 8, XP002029808 * |
E. L. PLUMMER ET. AL.: "Heterocyclic Analogues of Substituted (1,1'-Biphenyl)-3-methyl pyrethroid Insecticides.", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 32, no. 5, September 1984 (1984-09-01), WASHINGTON DC, US, pages 1116 - 21, XP000653215 * |
J. F. K. WILSHIRE: "The Preparation of 2-Fluoro-5-nitrobenzonitrile and the Proton Magnetic Resonance Spectra of some Compounds Containing the N-(2-Cyano-4-nitrophenyl) Group.", AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 20, no. 10, October 1967 (1967-10-01), MELBOURNE, AU, pages 1663 - 70, XP000653236 * |
J. F. K. WILSHIRE: "The Preparation of 4-Fluoro-3-nitrobenzonitrile and the Proton Magnetic Resonance Spectra of some Compounds Containing the N-4-Cyano-2-nitrophenyl Group.", AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 20, no. 10, October 1967 (1967-10-01), MELBOURNE, AU, pages 2269 - 73, XP000653235 * |
J. OHMORI ET. AL.: "6-(1H-Imidazol-1-yl)-7-nitro-2,3-(1H,4H) quinoxazolinedione Hydrochloride (YM90K) and Related Compounds. Structure-activity Relationships for the AMPA-Type Non-NMDA Receptor.", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 4, 18 February 1994 (1994-02-18), WASHINGTON DC, US, pages 467 - 75, XP002029804 * |
J. W. LAMPE ET. AL.: "A Novel Rearangement of 1-(2-Aminoaryl)imidazoles.", JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 31, no. 2, March 1994 (1994-03-01), pages 287 - 91, XP000653292 * |
P. FRANCHETTI ET. AL.: "Structure-Activity Relationships in Reactions of Organophosphorus Inhibited Acetylcholinesterase. 7. 1-Aryl-2-hydroxyiminomethyl-3-methylimidazolium Iodides.", JOURNAL OF MEDICINAL CHEMISTRY, vol. 17, no. 1, January 1974 (1974-01-01), WASHINGTON DC, US, pages 18 - 22, XP000653251 * |
P. STREHLKE: "Antifungale Imidazolverbindungen II. Äther von (1-Imidazolyl)- phenolen.", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, CHIMICA THERAPEUTICA, vol. 14, no. 3, May 1979 (1979-05-01), pages 227 - 30, XP000653317 * |
R. G. R. BACON ET. AL.: "Metal Ions and Complexes in Organic Reactions. Part XVIII.", JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS I, no. 16, 1974, OXFORD, GB, pages 1970 - 5, XP000653267 * |
Also Published As
Publication number | Publication date |
---|---|
EP0857171A2 (de) | 1998-08-12 |
AU1300997A (en) | 1997-05-15 |
DE19541146A1 (de) | 1997-04-30 |
JPH11515008A (ja) | 1999-12-21 |
CA2235621A1 (en) | 1997-05-01 |
ZA969019B (en) | 1997-05-29 |
WO1997015555A2 (de) | 1997-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997015555A3 (de) | Imidazolderivate und deren verwendung als stickstoffmonoxid-synthase-inhibitoren | |
IL148288A0 (en) | Indolealkanol ester and indolealkylamide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
EP1060738A3 (de) | Karmin enthaltende selbstbräunende Zusammensetzung | |
AU4308397A (en) | Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors | |
WO2002009713A3 (de) | Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung | |
EP0811595A4 (de) | Hydrochalconderivate, diese enthaltende kosmetische zubereitungen, und verfahren zur herstellung derselben | |
CA2349330A1 (en) | Nitrogen containing heterobicycles as factor xa inhibitors | |
EP1037639A4 (de) | Heteroaryl-substituierte imidazol-verbindungen, deren pharmazeutische zusammensetzungen und verwendungen | |
AU6230098A (en) | Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors | |
HUP0103913A3 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
HUP0200623A3 (en) | 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors and pharmaceutical compositions containing them | |
AU4710499A (en) | Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds | |
AU6989800A (en) | Diamino-1,2,4-triazole-carboxylic and derivatives as gsk-3 inhibitors | |
WO2000066104A3 (en) | Ace-2 inhibiting compounds and methods of use thereof | |
HUP0203288A3 (en) | Pyrrole derivatives as phosphodiesterase vii inhibitors, pharmaceutical compositions containing them and their use | |
MX9800408A (es) | Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
WO2001010816A3 (de) | Substituierte 2-Dialkylaminoalkylbiphenyl-derivate | |
HUP0203422A3 (en) | Imidazole derivatives as phosphodiesterase vii inhibitors, process for their preparation and pharmaceutical compositions containing them | |
EP0861238A4 (de) | Hexahydro-5-imino-1,4-heteroazepinderivate als inhibitoren von stickstoffoxid-sythase | |
HUP9903492A2 (en) | Quinoline derivatives as type iv phosphodiesterase inhibitors, process for their preparation, pharmaceutical compositions containing the same and their use | |
HUP9900071A3 (en) | Tribenzimidazoles useful as topoisomerase i inhibitors, pharmaceutical compositions containing them and their use | |
WO2002050067A3 (en) | Pharmaceutical heterocyclic compounds | |
WO1999012933A3 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase | |
WO2002080914A3 (de) | VERWENDUNG VON SUBSTITUIERTEN IMIDAZO[1,2-a]-PYRIDINVERBINDUNGEN ALS ARZNEIMITTEL | |
CA2219359A1 (en) | Hydantoin derivatives as intermediates for pharmaceutical active compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AU AZ BB BG BR BY CA CN CZ EE GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK TJ TM TR TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AU AZ BB BG BR BY CA CN CZ EE GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK TJ TM TR TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996944573 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2235621 Country of ref document: CA Ref country code: CA Ref document number: 2235621 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1997 516208 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1996944573 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97516208 Format of ref document f/p: F |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996944573 Country of ref document: EP |